Title Collection Author Date
Big Pharma, Big Returns? Equity Research & Insights James Gard 15/03/21
Should You Invest in the Vaccine Makers? Equity Research & Insights Rentsje de Gruyter 19/01/21
Ignore Politics, Innovation is Driving Healthcare Stocks Fund Research & Insights James Gard 24/09/19
Glaxo's Vaccines Division Outperforms Equity Research & Insights James Gard 24/07/19
Reckitt Shares Rise After Suboxone Settlement Equity Research & Insights James Gard 11/07/19
Investor Views: High-Tech and Pharma Shares for my SIPP Investing for Retirement Emma Simon 24/04/19
Top Asian Healthcare Stocks Perspectives External Writer 09/04/19
How to Tap Into the Genetics Revolution Perspectives EdenTree 29/03/19
Can Healthcare Stocks Continue their 2018 Rally? Equity Research & Insights David Brenchley 30/01/19
GSK Pfizer Joint Venture No Impact on Company Value Equity Research & Insights Damien Conover, CFA 20/12/18
Healthcare Stocks Aren't Cheap But Offer Attractive Returns Equity Research & Insights Philip Straehl 22/11/18
Henderson Backs Two Tech Alternative Trusts Investment Trust Research & Insights David Brenchley 25/09/18
Healthcare: Profit from an Ageing Population Market Update Emma Wall 17/09/18
ETF Investors Look to Healthcare Stocks ETF Research & Insights David Brenchley 13/09/18
GlaxoSmithKline Shares Still Undervalued Equity Research & Insights Damien Conover 31/07/18
Shire Stock Undervalued Despite Takeover Bid Equity Research & Insights Karen Andersen, CFA 20/04/18
Can FTSE 100 Drug Giants Weather US Reforms? Equity Research & Insights Damien Conover 29/03/18
Takeda Takeover Bid for Shire: Analyst View Equity Research & Insights Karen Andersen, CFA 29/03/18
Novartis Deal Will Strengthen Glaxo's Dividend say Analysts Equity Research & Insights Damien Conover, CFA 28/03/18
Invesco's Mark Barnett: Why I'm Investing in Oil Equity Research & Insights David Brenchley 14/11/17
Woodford on: Lloyds, Barclays, RBS, Astra and Glaxo Equity Research & Insights David Brenchley 10/11/17
Glaxo Dividend Cut Unlikely say Analysts Equity Research & Insights Damien Conover 26/10/17
Revealed: The Funds Hit by AstraZeneca Slump Fund Research & Insights Karen Kwok 27/07/17
AstraZeneca Falls 16% as Drug Trial Falters Equity Research & Insights Emma Wall 27/07/17
Pfizer Offers Dividend Opportunity Equity Research & Insights Damien Conover, CFA 07/06/17
Biotech Trusts Trade at Discount Investment Trust Research & Insights Karen Kwok 26/05/17
Are Healthcare Stocks Too Expensive? Equity Research & Insights Dan Kemp 02/05/17
Will Trump’s Policies Provide a Boost or Brake on Healthcare Funds? Fund Research & Insights Sam Shaw 07/02/17
UK Pharma Stocks Fall as Trump Repeals Obamacare Equity Research & Insights Karen Kwok 02/02/17
Pharma Stocks Remain Undervalued Despite Clinton Loss Equity Research & Insights Karen Kwok 29/11/16
What Does President Trump Mean for Healthcare Stocks? Equity Research & Insights Damien Conover, CFA 10/11/16
Healthcare and Mining Stocks Gain On Trump Win Equity Research & Insights Karen Kwok 09/11/16
Hobson: Spread-betting is Gambling The Week Rodney Hobson 28/10/16
AstraZeneca Shares Upgraded Thanks to Weak Sterling Equity Research & Insights Damien Conover, CFA 24/10/16
Why Healthcare Stocks Will be the Real Winner of the US Election Equity Research & Insights Karen Kwok 26/09/16
How the US Election is Creating Investment Opportunities Equity Research & Insights Daniel Vaughan, CFA 26/04/16
JPMorgan: We're Shorting Emerging Markets Equity Research & Insights Emma Wall 22/04/16
US Election is the Biggest Challenge to Healthcare Stocks Equity Research & Insights Karen Kwok 14/04/16
Mining, Banks and Pharma: Investors' Top 10 Favourite Stocks Equity Research & Insights Karen Kwok 03/03/16
5 US Stocks with a Wide Stable Moat Equity Research & Insights Karen Kwok 23/02/16
Analysts Downgrade Shire Equity Research & Insights Stefan Quenneville, CFA 15/02/16
AstraZeneca Credit Rating Downgraded by Analysts Bond Investing Morningstar Credit Committee 03/12/15
AstraZeneca Fairly Valued after Solid Q3 Equity Research & Insights Damien Conover, CFA 10/11/15
Smith & Nephew Ripe for Takeover Bid say Analysts Equity Research & Insights Debbie S. Wang 20/10/15
Pharmaceutical Stocks Get Sales Boost from Clinical Report Equity Research & Insights Damien Conover, CFA 15/05/15
Investment Focus: AstraZeneca Equity Research & Insights Damien Conover, CFA 12/05/15
AstraZeneca is Overvalued Equity Research & Insights Damien Conover, CFA 27/04/15
4 Pharma Stocks Best Placed in Cancer Market Equity Research & Insights Stefan Quenneville, CFA 30/03/15
Smith & Nephew Improving But Shares Overvalued Equity Research & Insights Holly Cook 26/02/15
Outperforming Manager Picks 3 Stocks to Get Rich Slowly Fund Research & Insights Emma Wall 17/02/15
Page   1 of 2